Migraine Relief NDC 53943-305

Product information

Brand name (proprietary)

Migraine Relief

Generic name (nonproprietary)

acetaminophen, aspirin and caffeine

Active ingredients

Acetaminophen — 250 mg/1Aspirin — 250 mg/1Caffeine — 65 mg/1

Dosage form

Tablet

Route

Oral

Labeler

DISCOUNT DRUG MART

Product type

Over-the-counter drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 214039

Marketing start

Jan 11, 2024

Listing expires

Dec 31, 2026

Other FDA classes

Non-Steroidal (Chemical structure)Central Nervous System Stimulation (Physiologic effect)Cyclooxygenase Inhibitors (Mechanism)Decreased Platelet Aggregation (Physiologic effect)Decreased Prostaglandin Production (Physiologic effect)Xanthines (Chemical structure)

Identifiers

Product ID 53943-305_1acbe982-a76a-f1be-e063-6394a90abe33SPL ID 1acbe982-a76a-f1be-e063-6394a90abe33SPL set ID 0ac12ced-70b3-7bbe-e063-6394a90aad52RxCUI 308297UNII 362O9ITL9D, R16CO5Y76E, 3G6A5W338E

Pharmacologic class

Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N453943030503 followed by a unit qualifier and the quantity Copy

Package 53943-0305-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 214039

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.